查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1946064

全球疫苗遞送創新市場：預測（至2034年）－按疫苗類型、給藥途徑、技術、應用、最終用戶和地區進行分析

Vaccine Delivery Innovations Market Forecasts to 2034 - Global Analysis By Vaccine Type, Route of Administration, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的研究，預計到 2026 年，全球疫苗輸送創新市場將達到 85.9 億美元，在預測期內以 8.3% 的複合年成長率成長，到 2034 年將達到 162.7 億美元。

疫苗遞送創新是指旨在改善疫苗接種方式、提高疫苗效力、安全性和可近性的先進技術和方法。這些創新包括無針注射器、微針貼片、奈米顆粒平台、口服、鼻腔和肺部給藥系統，以及植入式和經皮裝置。透過提高患者依從性、減少疼痛和針刺傷，並實現標靶化或劑量最佳化給藥，這些解決方案能夠最佳化免疫接種效果。疫苗遞送創新在支持常規免疫接種計劃、應對疫情和臨床研究以及擴大全球安全有效疫苗的可及性方面發揮著至關重要的作用。

全球免疫計劃的擴展

全球疫苗遞送創新市場正受到全球免疫規劃擴展的顯著推動。各國政府和衛生組織正日益積極地實施疫苗接種舉措，以預防感染疾病並改善公共衛生狀況。這些計劃需要安全且有效率的給藥方案，以最大限度地提高疫苗接種率，尤其是在兒童和弱勢群體中。採用包括無針和微針系統在內的先進技術，將有助於大規模免疫宣傳活動，提高病患依從性，並加強全球疾病預防工作。

高昂的開發和設備成本

高昂的研發和設備成本是疫苗遞送創新市場的主要阻礙因素。微針貼片、奈米顆粒平台和植入式系統等先進遞送技術需要大量的研發投入、合規性要求和專門的生產流程。這些成本通常會反映在產品定價中，從而可能限制價格敏感地區和開發中國家的採用。因此，醫療機構可能繼續依賴傳統的注射方法，這可能會減緩創新遞送方案的普及。

技術進步

科技進步為疫苗遞送創新市場帶來了巨大的成長機會。諸如無針注射器、微針貼片和奈米顆粒平台等新型解決方案，提高了安全性，減輕了疼痛，並增強了患者依從性。口服和肺部給藥方式的創新拓展了給藥途徑，並實現了標靶給藥和劑量最佳化。在這些領域持續進行研發，有助於提高疫苗接種率，支持臨床試驗，並增強應對突發公共衛生事件的能力，從而使技術成為未來市場成長的關鍵驅動力。

物流和基礎設施挑戰

物流和基礎設施的挑戰對疫苗遞送創新技術的應用構成威脅。先進的管理系統通常需要專門的儲存設施、低溫運輸管理和訓練有素的人員，這在偏遠或資源匱乏地區難以維持。配送的複雜性、醫療基礎設施的差異以及供應鏈中斷都可能導致疫苗接種計劃的延誤，並降低創新技術的應用。克服這些障礙對於確保有效的免疫宣傳活動以及在全球範圍內最大限度地發揮疫苗遞送創新技術的潛力至關重要。

新冠疫情的影響：

新冠疫情對疫苗遞送創新市場產生了雙重影響。一方面，供應鏈和常規免疫接種計劃一度中斷；另一方面，疫情加速了mRNA疫苗、無針注射器和微針貼片等先進遞送技術的研發和應用。大眾對疫苗安全性和免疫接種重要性的認知不斷提高，也推動了對創新給藥方式的需求。疫情後，對疫情應對、強化分銷基礎設施和居家免疫接種舉措的投資預計將進一步促進市場成長。

在預測期內，皮下給藥領域預計將佔據最大的市場佔有率。

由於皮下注射的廣泛應用及其在多種疫苗接種方面的靈活性，預計在預測期內，皮下注射仍將佔據最大的市場佔有率。皮下注射因其能夠精準給藥並減少全身副作用，是兒童疫苗、常規免疫接種計畫和某些治療性疫苗的首選給藥方式。醫療機構和醫護人員也因其安全性、可靠性和易用性而支持這種方法。因此，在傳統和創新疫苗接種途徑中，皮下注射繼續佔據市場主導地位。

預計在預測期內，兒童疫苗領域將呈現最高的複合年成長率。

在預測期內，由於全球嬰幼兒免疫接種活動的擴大，兒童疫苗領域預計將呈現最高的成長率。政府免疫接種計劃和創新給藥技術的普及正在推動疫苗的推廣應用。無針注射器、微針貼片和口服疫苗透過減少傳統注射帶來的疼痛和恐懼，提高了兒童的接種依從性。公共衛生重視程度的提高和技術應用的協同效應，使兒童疫苗成為疫苗給藥創新市場中成長最快的細分領域。

市佔率最大的地區：

在預測期內，北美預計將保持最大的市場佔有率，這主要得益於其對先進疫苗輸送技術的高採用率以及政府和私營部門在免疫規劃方面的大量投資。主要市場參與者的存在、積極的研發活動以及對無針注射器、微針貼片和奈米顆粒平台等創新技術的早期應用，都鞏固了該地區的市場主導地位。此外，人們對疫苗安全性和常規免疫規劃的高度重視也持續推動了對創新疫苗傳遞解決方案的強勁需求。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於人口成長、醫療保健支出增加以及免疫意識的提高。政府資助的疫苗接種計劃的擴大、醫療基礎設施的改善以及微針貼片、口服疫苗和無針系統等先進遞送技術的應用，都推動了該地區的快速成長。隨著中國、印度和東南亞等新興市場的疫苗供應和分發力度加強，亞太地區已成為疫苗遞送創新領域成長最快的地區。

免費客製化服務：

訂閱本報告的用戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他公司（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣量身定做的主要國家/地區的市場估算、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對主要企業進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 成長要素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 科技與創新趨勢
  • 新興市場和高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要企業市佔率分析
  • 產品基準評效和效能比較

第5章：全球疫苗遞送創新市場：依疫苗類型分類

  • 感染疾病疫苗
  • 藥效疫苗
  • 病毒載體疫苗
  • 癌症免疫療法疫苗
  • 兒童疫苗
  • 其他疫苗類型

第6章：全球疫苗遞送創新市場：依給藥途徑分類

  • 肌肉內部
  • 皮內注射
  • 皮下
  • 口服
  • 鼻內
  • 肺內

第7章：全球疫苗遞送創新市場：依技術分類

  • 傳統注射系統
  • 無針注射器
  • 微針貼片系統
  • 基於奈米顆粒的遞送平台
  • 口服疫苗
  • 鼻腔和肺部給藥
  • 經皮疫苗遞送
  • 嵌入式交付系統

第8章：全球疫苗遞送創新市場：依應用領域分類

  • 常規免疫接種計劃
  • 大流行病/疫情應對
  • 旅行者和成人的疫苗接種
  • 動物疫苗接種
  • 臨床研究和試驗

第9章：全球疫苗遞送創新市場：依最終用戶分類

  • 醫院和診所
  • 疫苗接種中心
  • 社區健康計劃
  • 研究機構和學術機構
  • 製藥和生物技術公司

第10章：全球疫苗遞送創新市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 南美洲其他地區
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 產業加值網路與供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 企業合併（M&A）
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Becton, Dickinson and Company
  • Terumo Corporation
  • Nipro Corporation
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • SCHOTT AG
  • PharmaJet, Inc.
  • Vaxxas Pty Ltd
  • Micron Biomedical, Inc.
  • AptarGroup, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi SA
  • Moderna, Inc.
  • BioNTech SE
Product Code: SMRC33838

According to Stratistics MRC, the Global Vaccine Delivery Innovations Market is accounted for $8.59 billion in 2026 and is expected to reach $16.27 billion by 2034 growing at a CAGR of 8.3% during the forecast period. Vaccine delivery innovations refer to advanced technologies and methods designed to improve the administration, efficacy, safety, and accessibility of vaccines. These innovations include needle-free injectors, micro needle patches, nanoparticles based platforms, oral, intranasal, and pulmonary delivery systems, as well as implantable and Transdermal devices. By enhancing patient compliance, reducing pain and needle stick injuries, and enabling targeted or dose-sparing delivery, these solutions optimize immunization outcomes. Vaccine delivery innovations play a crucial role in supporting routine immunization programs, pandemic responses, and clinical research, while expanding access to safe and effective vaccines globally.

Market Dynamics:

Driver:

Expansion of Global Immunization Programs

The global vaccine delivery innovations market is being significantly driven by the expansion of immunization programs worldwide. Governments and health organizations are increasingly implementing vaccination initiatives to prevent infectious diseases and improve public health outcomes. These programs demand safe and efficient delivery solutions to maximize coverage, especially in children and vulnerable populations. Adoption of advanced technologies, including needle-free and micro-needle systems, supports mass immunization campaigns, enhances patient compliance, and strengthens global efforts toward disease prevention.

Restraint:

High Development and Device Costs

High development and device costs are a key restraint for the vaccine delivery innovations market. Advanced delivery technologies such as micro needle patches, nanoparticles platforms, and implantable systems require substantial research, regulatory compliance, and specialized manufacturing processes. These costs are often reflected in product pricing, which can limit adoption in price sensitive regions or developing countries. As a result, healthcare providers may continue relying on conventional injection methods, slowing the uptake of innovative delivery solutions.

Opportunity:

Technological Advancements

Technological advancements present a significant growth opportunity for the vaccine delivery innovations market. Emerging solutions, including needle free injectors, micro needle patches, and nanoparticles based platforms, improve safety, reduce pain, and enhance patient compliance. Innovations in oral and pulmonary delivery expand administration options and enable targeted, dose-sparing approaches. Continued research and development in these areas open opportunities for expanding vaccine coverage, supporting clinical trials, and addressing public health emergencies, positioning technology as a key driver for future market growth.

Threat:

Logistical and Infrastructure Challenges

Logistical and infrastructure challenges pose a threat to the adoption of vaccine delivery innovations. Advanced delivery systems often require specialized storage, cold chain management, and trained personnel, which can be difficult to maintain in remote or resource-limited regions. Distribution complexities, inconsistent healthcare infrastructure, and supply chain disruptions may delay vaccination programs, reducing access to innovative technologies. Addressing these barriers is essential to ensure effective immunization campaigns and achieve the full potential of vaccine delivery innovations globally.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the vaccine delivery innovations market. While supply chains and routine vaccination programs were temporarily disrupted, the crisis accelerated research, development, and adoption of advanced delivery technologies such as mRNA vaccines, needle free injectors, and micro needle patches. Increased public awareness of vaccine safety and immunization importance spurred demand for innovative delivery methods. Post-pandemic, investment in pandemic preparedness, enhanced distribution infrastructure, and home-based immunization initiatives are expected to further boost market growth.

The subcutaneous segment is expected to be the largest during the forecast period

The subcutaneous segment is expected to account for the largest market share during the forecast period, due to its widespread use and versatility in delivering a wide range of vaccines. Subcutaneous administration is preferred for pediatric vaccines, routine immunization programs, and certain therapeutic vaccines because it allows precise dosing and reduces systemic side effects. Healthcare providers and institutions favor this method for its safety, reliability, and familiarity. Consequently, subcutaneous delivery continues to dominate the market among conventional and innovative vaccine administration routes.

The pediatric vaccines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pediatric vaccines segment is predicted to witness the highest growth rate, due to increasing vaccination initiatives for children and infants worldwide. Government immunization programs and growing access to innovative delivery technologies drive adoption. Needle free injectors, micro needle patches, and oral vaccines improve compliance in children by reducing pain and fear associated with traditional injections. The combination of public health focus and technological adoption positions pediatric vaccines as the fastest-growing segment in the vaccine delivery innovations market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high adoption of advanced vaccine delivery technologies, and significant government and private investment in immunization programs. The presence of key market players, robust R&D activities, and early adoption of innovations such as needle free injectors, micro needle patches, and nanoparticles based platforms support market dominance. Additionally, high awareness of vaccine safety and routine immunization programs sustains strong demand for innovative delivery solutions in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing population, growing healthcare expenditure, and rising awareness of immunization. Expansion of government funded vaccination programs, improved healthcare infrastructure, and adoption of advanced delivery technologies such as micro needle patches, oral vaccines, and needle free systems are driving rapid growth. Emerging markets including China, India, and Southeast Asia are witnessing increased vaccine accessibility and distribution initiatives, making Asia Pacific the fastest growing region for vaccine delivery innovations.

Key players in the market

Some of the key players in Vaccine Delivery Innovations Market include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, West Pharmaceutical Services, Inc., Gerresheimer AG, SCHOTT AG, PharmaJet, Inc., Vaxxas Pty Ltd, Micron Biomedical, Inc., AptarGroup, Inc., Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Moderna, Inc. and BioNTech SE

Key Developments:

In January 2026, Pfizer and Cartography Biosciences forged a multi-year collaboration to use Cartography's ATLAS and SUMMIT discovery platforms to pinpoint tumor-selective antigens for future cancer therapies, with Pfizer funding research and holding development and commercialization rights.

In December 2025, Pfizer struck an exclusive global collaboration and license deal with YaoPharma to develop, manufacture, and commercialize YP05002, an oral GLP 1 weight management agent, advancing its cardiometabolic pipeline with upfront and milestone payments and potential worldwide impact.

Vaccine Types Covered:

  • Infectious Disease Vaccines
  • mRNA Vaccines
  • Viral Vector Vaccines
  • Cancer Immunotherapy Vaccines
  • Pediatric Vaccines
  • Other Vaccine Types

Route of Administrations Covered:

  • Intramuscular
  • Intradermal
  • Subcutaneous
  • Oral
  • Nasal
  • Pulmonary

Technologies Covered:

  • Traditional Injectable Systems
  • Needle-Free Injectors
  • Microneedle Patch Systems
  • Nanoparticle-Based Delivery Platforms
  • Oral Vaccine Delivery
  • Intranasal & Pulmonary Delivery
  • Transdermal Vaccine Delivery
  • Implantable Delivery Systems

Applications Covered:

  • Routine Immunization Programs
  • Pandemic/Epidemic Response
  • Travel & Adult Immunization
  • Veterinary Vaccine Delivery
  • Clinical Research & Trials

End Users Covered:

  • Hospitals & Clinics
  • Vaccination Centers
  • Community Health Programs
  • Research Institutes & Academia
  • Pharmaceutical & Biotech Firms

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Vaccine Delivery Innovations Market, By Vaccine Type

  • 5.1 Infectious Disease Vaccines
  • 5.2 mRNA Vaccines
  • 5.3 Viral Vector Vaccines
  • 5.4 Cancer Immunotherapy Vaccines
  • 5.5 Pediatric Vaccines
  • 5.6 Other Vaccine Types

6 Global Vaccine Delivery Innovations Market, By Route of Administration

  • 6.1 Intramuscular
  • 6.2 Intradermal
  • 6.3 Subcutaneous
  • 6.4 Oral
  • 6.5 Nasal
  • 6.6 Pulmonary

7 Global Vaccine Delivery Innovations Market, By Technology

  • 7.1 Traditional Injectable Systems
  • 7.2 Needle Free Injectors
  • 7.3 Microneedle Patch Systems
  • 7.4 Nanoparticle Based Delivery Platforms
  • 7.5 Oral Vaccine Delivery
  • 7.6 Intranasal & Pulmonary Delivery
  • 7.7 Transdermal Vaccine Delivery
  • 7.8 Implantable Delivery Systems

8 Global Vaccine Delivery Innovations Market, By Application

  • 8.1 Routine Immunization Programs
  • 8.2 Pandemic/Epidemic Response
  • 8.3 Travel & Adult Immunization
  • 8.4 Veterinary Vaccine Delivery
  • 8.5 Clinical Research & Trials

9 Global Vaccine Delivery Innovations Market, By End User

  • 9.1 Hospitals & Clinics
  • 9.2 Vaccination Centers
  • 9.3 Community Health Programs
  • 9.4 Research Institutes & Academia
  • 9.5 Pharmaceutical & Biotech Firms

10 Global Vaccine Delivery Innovations Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Becton, Dickinson and Company
  • 13.2 Terumo Corporation
  • 13.3 Nipro Corporation
  • 13.4 West Pharmaceutical Services, Inc.
  • 13.5 Gerresheimer AG
  • 13.6 SCHOTT AG
  • 13.7 PharmaJet, Inc.
  • 13.8 Vaxxas Pty Ltd
  • 13.9 Micron Biomedical, Inc.
  • 13.10 AptarGroup, Inc.
  • 13.11 Pfizer Inc.
  • 13.12 GlaxoSmithKline plc
  • 13.13 Sanofi S.A.
  • 13.14 Moderna, Inc.
  • 13.15 BioNTech SE

List of Tables

  • Table 1 Global Vaccine Delivery Innovations Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Vaccine Delivery Innovations Market Outlook, By Vaccine Type (2023-2034) ($MN)
  • Table 3 Global Vaccine Delivery Innovations Market Outlook, By Infectious Disease Vaccines (2023-2034) ($MN)
  • Table 4 Global Vaccine Delivery Innovations Market Outlook, By mRNA Vaccines (2023-2034) ($MN)
  • Table 5 Global Vaccine Delivery Innovations Market Outlook, By Viral Vector Vaccines (2023-2034) ($MN)
  • Table 6 Global Vaccine Delivery Innovations Market Outlook, By Cancer Immunotherapy Vaccines (2023-2034) ($MN)
  • Table 7 Global Vaccine Delivery Innovations Market Outlook, By Pediatric Vaccines (2023-2034) ($MN)
  • Table 8 Global Vaccine Delivery Innovations Market Outlook, By Other Vaccine Types (2023-2034) ($MN)
  • Table 9 Global Vaccine Delivery Innovations Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 10 Global Vaccine Delivery Innovations Market Outlook, By Intramuscular (2023-2034) ($MN)
  • Table 11 Global Vaccine Delivery Innovations Market Outlook, By Intradermal (2023-2034) ($MN)
  • Table 12 Global Vaccine Delivery Innovations Market Outlook, By Subcutaneous (2023-2034) ($MN)
  • Table 13 Global Vaccine Delivery Innovations Market Outlook, By Oral (2023-2034) ($MN)
  • Table 14 Global Vaccine Delivery Innovations Market Outlook, By Nasal (2023-2034) ($MN)
  • Table 15 Global Vaccine Delivery Innovations Market Outlook, By Pulmonary (2023-2034) ($MN)
  • Table 16 Global Vaccine Delivery Innovations Market Outlook, By Technology (2023-2034) ($MN)
  • Table 17 Global Vaccine Delivery Innovations Market Outlook, By Traditional Injectable Systems (2023-2034) ($MN)
  • Table 18 Global Vaccine Delivery Innovations Market Outlook, By Needle Free Injectors (2023-2034) ($MN)
  • Table 19 Global Vaccine Delivery Innovations Market Outlook, By Microneedle Patch Systems (2023-2034) ($MN)
  • Table 20 Global Vaccine Delivery Innovations Market Outlook, By Nanoparticle Based Delivery Platforms (2023-2034) ($MN)
  • Table 21 Global Vaccine Delivery Innovations Market Outlook, By Oral Vaccine Delivery (2023-2034) ($MN)
  • Table 22 Global Vaccine Delivery Innovations Market Outlook, By Intranasal & Pulmonary Delivery (2023-2034) ($MN)
  • Table 23 Global Vaccine Delivery Innovations Market Outlook, By Transdermal Vaccine Delivery (2023-2034) ($MN)
  • Table 24 Global Vaccine Delivery Innovations Market Outlook, By Implantable Delivery Systems (2023-2034) ($MN)
  • Table 25 Global Vaccine Delivery Innovations Market Outlook, By Application (2023-2034) ($MN)
  • Table 26 Global Vaccine Delivery Innovations Market Outlook, By Routine Immunization Programs (2023-2034) ($MN)
  • Table 27 Global Vaccine Delivery Innovations Market Outlook, By Pandemic/Epidemic Response (2023-2034) ($MN)
  • Table 28 Global Vaccine Delivery Innovations Market Outlook, By Travel & Adult Immunization (2023-2034) ($MN)
  • Table 29 Global Vaccine Delivery Innovations Market Outlook, By Veterinary Vaccine Delivery (2023-2034) ($MN)
  • Table 30 Global Vaccine Delivery Innovations Market Outlook, By Clinical Research & Trials (2023-2034) ($MN)
  • Table 31 Global Vaccine Delivery Innovations Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Vaccine Delivery Innovations Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 33 Global Vaccine Delivery Innovations Market Outlook, By Vaccination Centers (2023-2034) ($MN)
  • Table 34 Global Vaccine Delivery Innovations Market Outlook, By Community Health Programs (2023-2034) ($MN)
  • Table 35 Global Vaccine Delivery Innovations Market Outlook, By Research Institutes & Academia (2023-2034) ($MN)
  • Table 36 Global Vaccine Delivery Innovations Market Outlook, By Pharmaceutical & Biotech Firms (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.